Corpus Intelligence IC Memo — MONROVIA MEMORIAL HOSPITAL 2026-04-26 19:00 UTC
IC Memo — MONROVIA MEMORIAL HOSPITAL
Investment Committee Memorandum | CA | 49 beds | Grade F | EBITDA uplift $1.3M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

MONROVIA MEMORIAL HOSPITAL

CCN 052054 | LOS ANGELES, CA | 49 beds | April 26, 2026
EBITDA BridgeData Room
F
Investability

1. Target Overview & Investment Thesis

MONROVIA MEMORIAL HOSPITAL is a 49-bed community hospital in LOS ANGELES, CA with $17.8M in net patient revenue and a -1.5% operating margin. The hospital serves a payer mix of 93.1% Medicare, 0.0% Medicaid, and 6.9% commercial.

Thesis: Turnaround. Our ML models identify $1.3M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -1.5% to 5.9% (+736bps).

Net Revenue HCRIS$17.8M
Current EBITDA COMPUTED$-261K
Operating Margin COMPUTED-1.5%
Occupancy HCRIS38.5%
Revenue / Bed COMPUTED$363K
Net-to-Gross HCRIS15.6%
Distress Probability MLnan%

2. Market Context & Competitive Position

414
CA Hospitals
-4.9%
State Median Margin
102
Comparable Hospitals

CA has 414 Medicare-certified hospitals with a median operating margin of -4.9%. The target's margin of -1.5% places it above the state median. Among 102 size-comparable peers (24-98 beds), the median margin is -4.8%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (24-98), prioritizing same-state peers. 102 hospitals in the comp set.

HospitalStateBedsRevenueMargin
MONROVIA MEMORIAL HOSPITAL (Target)CA49$17.8M-1.5%
RANCHO LOS AMIGOS NATL.REHAB.CCA83$512.6M41.9%
USC NORRIS CANCER HOSPITALCA60$468.7M19.1%
ADVENTIST HEALTH SONORACA84$274.3M-7.4%
TAHOE FOREST HOSPITALCA25$264.3M13.0%
WOODLAND HEALTHCARECA74$211.5M-3.2%
FRENCH HOSPITAL MEDICAL CENTERCA98$208.6M-2.1%
PALOMAR MEDICAL CENTER POWAYCA95$203.9M-3.6%
KFH - MORENO VALLEYCA94$200.5M-0.5%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.3M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$374K+210bp18mo
Cost to Collect4.5%2.5%$356K+200bp12mo
Denial Rate Reduction12.0%6.5%$353K+198bp12mo
A/R Days Reduction5200.0%3800.0%$217K+122bp9mo
Clean Claim Rate88.0%96.0%$11K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$374K
Cost to Collect
$356K
Denial Rate Reduction
$353K
A/R Days Reduction
$217K
Clean Claim Rate
$11K
Total EBITDA Uplift$1.3M
Current EBITDA$-261K
+ RCM Uplift+$1.3M
Pro Forma EBITDA$1.1M
Current Margin-1.5%
Pro Forma Margin5.9%
WC Released (1x)$683K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-401K$11.4M0.00x-100.0%
Base (11x exit)10.0x11.0x$-401K$12.4M0.00x-100.0%
Bull Case9.0x11.0x$-361K$16.6M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-361K$18.0M0.00x-100.0%
Bear Case11.0x10.0x$-441K$5.0M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-441K$5.3M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumHeavy Medicare dependenceMedicare comprises 93.1% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 102 hospitals with 24-98 beds
  • Same-state prioritization (n=103)
  • Comp margins: P25=-18.6% / P50=-4.8% / P75=1.8%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.